Maker of highly criticized painkiller asks FDA to approve new, harder-to-abuse version

The maker of the much-debated painkiller Zohydro is seeking approval of a harder-to-abuse version of its drug which, if approved, could replace the currently marketed version of the pill by next spring.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.